ASH 2013: The Future of Genomics & Personalized Medicine: Closing Thoughts From the Panel

Joining Vital Options CEO, Selma SchimmelThe Future of Genomics & Personalized Medicine: Keith Stewart, MD, Mayo Clinic; Anne Quinn Young, MPH, Multiple Myeloma Research Foundation (MMF); Scott Riccio, Leukemia and Lymphoma Society (LLS); Meghan Gutierrez, Lymphoma Research Foundation (LRF).

In this segment the panel discusses their closing thoughts on the topic of genomics and personalized medicine as it relates to hematologic cancers.

ASH 2013 Sponsors

Comments